Michael Hallek
Cited by
Cited by
Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National …
M Hallek, BD Cheson, D Catovsky, F Caligaris-Cappio, G Dighiero, ...
Blood, The Journal of the American Society of Hematology 111 (12), 5446-5456, 2008
Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial
M Hallek, K Fischer, G Fingerle-Rowson, AM Fink, R Busch, J Mayer, ...
The Lancet 376 (9747), 1164-1174, 2010
Idelalisib and rituximab in relapsed chronic lymphocytic leukemia
RR Furman, JP Sharman, SE Coutre, BD Cheson, JM Pagel, P Hillmen, ...
New England Journal of Medicine 370 (11), 997-1007, 2014
Obinutuzumab plus chlorambucil in patients with CLL and coexisting conditions
V Goede, K Fischer, R Busch, A Engelke, B Eichhorst, CM Wendtner, ...
New England Journal of Medicine 370 (12), 1101-1110, 2014
Comprehensive genomic profiles of small cell lung cancer
J George, JS Lim, SJ Jang, Y Cun, L Ozretić, G Kong, F Leenders, X Lu, ...
Nature 524 (7563), 47-53, 2015
Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer
M Peifer, L Fernández-Cuesta, ML Sos, J George, D Seidel, LH Kasper, ...
Nature genetics 44 (10), 1104-1110, 2012
Real-time single-molecule imaging of the infection pathway of an adeno-associated virus
G Seisenberger, MU Ried, T Endress, H Buning, M Hallek, C Brauchle
Science 294 (5548), 1929-1932, 2001
iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL
M Hallek, BD Cheson, D Catovsky, F Caligaris-Cappio, G Dighiero, ...
Blood, The Journal of the American Society of Hematology 131 (25), 2745-2760, 2018
Multiple myeloma: increasing evidence for a multistep transformation process
M Hallek, PL Bergsagel, KC Anderson
Blood 91 (1), 3, 1998
Frequent and focal FGFR1 amplification associates with therapeutically tractable FGFR1 dependency in squamous cell lung cancer
J Weiss, ML Sos, D Seidel, M Peifer, T Zander, JM Heuckmann, RT Ullrich, ...
Science translational medicine 2 (62), 62ra93-62ra93, 2010
Mutations driving CLL and their evolution in progression and relapse
DA Landau, E Tausch, AN Taylor-Weiner, C Stewart, JG Reiter, J Bahlo, ...
Nature 526 (7574), 525-530, 2015
Fludarabine plus cyclophosphamide versus fludarabine alone in first-line therapy of younger patients with chronic lymphocytic leukemia
BF Eichhorst, R Busch, G Hopfinger, R Pasold, M Hensel, C Steinbrecher, ...
Blood 107 (3), 885-891, 2006
Chronic lymphocytic leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
B Eichhorst, T Robak, E Montserrat, P Ghia, P Hillmen, M Hallek, C Buske
Annals of Oncology 26 (suppl 5), v78-v84, 2015
Venetoclax in relapsed or refractory chronic lymphocytic leukaemia with 17p deletion: a multicentre, open-label, phase 2 study
S Stilgenbauer, B Eichhorst, J Schetelig, S Coutre, JF Seymour, T Munir, ...
The lancet oncology 17 (6), 768-778, 2016
TP53 Mutation and Survival in Chronic Lymphocytic Leukemia
T Zenz, B Eichhorst, R Busch, T Denzel, S Häbe, D Winkler, A Bühler, ...
Journal of Clinical Oncology 28 (29), 4473-4479, 2010
Long-term remissions after FCR chemoimmunotherapy in previously untreated patients with CLL: updated results of the CLL8 trial
K Fischer, J Bahlo, AM Fink, V Goede, CD Herling, P Cramer, ...
Blood, The Journal of the American Society of Hematology 127 (2), 208-215, 2016
Reduced-intensity chemotherapy and PET-guided radiotherapy in patients with advanced stage Hodgkin's lymphoma (HD15 trial): a randomised, open-label, phase 3 non-inferiority trial
A Engert, H Haverkamp, C Kobe, J Markova, C Renner, A Ho, J Zijlstra, ...
The Lancet 379 (9828), 1791-1799, 2012
Reduced frequencies and suppressive function of CD4+ CD25hi regulatory T cells in patients with chronic lymphocytic leukemia after therapy with fludarabine
M Beyer, M Kochanek, K Darabi, A Popov, M Jensen, E Endl, PA Knolle, ...
Blood 106 (6), 2018-2025, 2005
First-line chemoimmunotherapy with bendamustine and rituximab versus fludarabine, cyclophosphamide, and rituximab in patients with advanced chronic lymphocytic leukaemia (CLL10 …
B Eichhorst, AM Fink, J Bahlo, R Busch, G Kovacs, C Maurer, E Lange, ...
The lancet oncology 17 (7), 928-942, 2016
Treatment of older patients with mantle-cell lymphoma
HC Kluin-Nelemans, E Hoster, O Hermine, J Walewski, M Trneny, ...
New England Journal of Medicine 367 (6), 520-531, 2012
The system can't perform the operation now. Try again later.
Articles 1–20